Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation

Switching of OAC After PCI in A-fib Patients:RE-DUAL PCI Trial Subanalysis

December 04, 2019

Presentation

Impact of Preexisting and New-Onset A-fib on TAVR Outcomes

October 18, 2019

Presentation TCT Abstracts Posters 2019

Non-ST Elevation Myocardial Infarction in Hospitalized Patients With Atrial Fibrillation

Presenter: Pengyang Li

October 05, 2019

Presentation TCT Abstracts Posters 2019

In-hospital Outcomes of Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: Nationwide Database Analysis

Presenter: Fangcheng Wu

September 29, 2019

Presentation TCT 2019

When the Primary Endpoint Is Missed: The CABANA Case Study

Presenter: Bernard Gersh

September 27, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation ARCH 2019

Rotablator Technique

Presenter: Howard Kurz

April 11, 2019

Presentation ARCH 2019

Practical Education: Tricks and Tools to Facilitate AF Ablation

Presenter: Sandeep Gautam

April 10, 2019

Presentation ARCH 2019

Live Case Presentation: Follow up

Presenter: Daniel H. Cooper

April 10, 2019

Presentation ARCH 2019

Electrophysiology Case Presentation Division of Cardiovascular Medicine

Presenter: Sandeep Sodhi

April 10, 2019

Presentation ARCH 2019

Cryoballon vs RF in 2019: Moving beyond Fire and Ice

Presenter: Jason Meyers

April 10, 2019

Presentation ARCH 2019

Case Presentation: Atrial Fibrillation

Presenter: Curtis M. Steyers III

April 10, 2019

Presentation

Case Presentation

Presenter: G. Joseph Orme

April 10, 2019

Presentation ACC 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presenter: Renato Lopes

March 18, 2019

Presentation

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

January 09, 2019

Advertisement

Switching of OAC After PCI in A-fib Patients:RE-DUAL PCI Trial Subanalysis

Impact of Preexisting and New-Onset A-fib on TAVR Outcomes

Non-ST Elevation Myocardial Infarction in Hospitalized Patients With Atrial Fibrillation

In-hospital Outcomes of Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: Nationwide Database Analysis

When the Primary Endpoint Is Missed: The CABANA Case Study

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Rotablator Technique

Practical Education: Tricks and Tools to Facilitate AF Ablation

Live Case Presentation: Follow up

Electrophysiology Case Presentation Division of Cardiovascular Medicine

Cryoballon vs RF in 2019: Moving beyond Fire and Ice

Case Presentation: Atrial Fibrillation

Case Presentation

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content